MANNING ANTHONY M. (Chief Scientific Officer) sold 36.4% of their position (7.31K shares) of MOMENTA PHARMACEUTICALS INC on the open market
Open‑market sale worth $212.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/9/2020ACC: 0001179110-20-003312
Officer· Chief Scientific Officer
Since Oct 2018
+22.69K
Net shares
Net buyer
$212.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
30K acquired · 7.31K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15K
Price / share
—
Trade value
—
% of position
296.0%
3/5/2020
5.07K→20.07K
Common Stock
Direct
Shares
−7.31K
Price / share
$29.00
Trade value
$211.99K
% of position
36.4%
3/6/2020
20.07K→12.76K
Total
Net shares
+7.69K
Net value
-$211.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2020 | A · Award | +15K | — | — | 296.0% | 5.07K | 20.07K |
| Common Stock Direct | 3/6/2020 | S · Sale | −7.31K | $29.00 | $211.99K | 36.4% | 20.07K | 12.76K |
| Total | +7.69K | -$211.99K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
15K shares
Shares
+15K
Strike price
Held after
15K
Exercisable
—
3/5/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock15K shares | 3/5/2020 | A · Award | +15K | — | 15K |